News
Ultrasound-detected dactylitis lesions may help identify patients with psoriasis who are at risk for psoriatic arthritis and ...
Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic ...
Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage ...
Morning finger stiffness can be a subtle sign of early arthritis. Learn what to watch for and how early intervention can help ...
A Personal Independence Payment rate will pay claimants £749 each month if you have a muscle or joint condition. 87 ...
9d
MedPage Today on MSNMomentum for Oral Therapies to Treat Plaque PsoriasisA growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...
I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.
Eli Lilly and Company, Corcept Therapeutics, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks represent the publicly ...
UCB SA (OTCMKTS:UCBJY – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $95.59 and traded ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain for investors.
We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...
13d
Zacks.com on MSNRDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi BiosimilarDr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results